Non-small cell lung cancer

• BEAMION Lung-2: A study to test whether zongertinib (BI 1810631) helps people with advanced non-small cell lung cancer with HER2 mutations c … Recruiting
  2023-504308-27-00 5 2024-06-06 "non-squamous non-small cell lung cancer"
• A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced … Recruiting
  2023-503221-19-00 4 2024-04-18 "Advanced Non-Small Cell Lung Cancer"
• A Study of Repotrectinib versus Crizotinib in Participants with Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-po … Recruiting
  2023-505604-32-00 5 2024-01-24 "Non small cell lung cancer (NSCLC)"
• A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III N … Recruiting
  2023-503920-14-00 5 2024-01-02 "Non-Small Cell Lung Cancer (NSCLC)"
• A Multicenter, Open-Label, Dose-Finding, Phase 2 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) in Subjects with Advanced Non-Sm … Recruiting
  2023-504595-26-00 4 2023-05-22 "Non-Small Cell Lung Cancer"
• A Phase 1 first in human study evaluating safety, pharmacokinetics and efficacy of ABBV-400 as monotherapy and in combination with bevacizum … Recruiting
  2023-509335-60-00 1 2023-02-23 "Advanced solid tumors including (but not limited to), non-sm"
• A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Furmonertinib in Patients with Non-Small Cell Lung Cancer with A … Recruiting
  2023-508349-42-00 3 2022-10-18 "Non-Small Cell Lung Cancer (NSCLC) harboring activating EGFR"
• First in human study of BAY2927088 in participants who have advanced non-small cell lung cancer (NSCLC) with mutations in the genes of epide … Recruiting
  2023-503795-24-00 7 2022-09-16 "Avanced Non-Small Cell Lung Cancer"
• Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies Recruiting
  2024-513033-21-00 3 2020-09-14 "Non-small cell lung cancer (NSCLC)"
• A randomized, non-comparative, phase II study investigating the best epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) s … Recruiting
  2024-518223-29-00 4 2020-03-10 "Advanced or metastatic untreated EGFR mutation positive NSCL"
• A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and s … Recruiting
  2025-521702-18-00 1 2026-05-21 "Locally advanced unresectable or metastatic colorectal cance"
• Study of STK-012 Alone and with Other Treatments in Patients with Advanced Lung Cancer and Other Cancers Recruiting
  2025-522632-14-00 4 2026-05-11 "Non-small cell lung cancer (NSCLC)"
• A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-8520 in Subjects with Advanced KRA … Recruiting
  2024-512515-45-01 1 2026-04-10 "Non-Small Cell Lung Cancer"
• A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with … Recruiting
  2024-519344-32-00 9 2026-03-16 "Non-small Cell Lung Cancer"
• A Phase 2 study of zanidatamab in patients with HER2-expressing tumors Recruiting
  2024-516551-41-00 4 2026-03-06 "Patients with HER2-expressing solid tumors"
• Beamion LUNG-3: A study to test whether zongertinib helps people with surgically removed, non-small cell lung cancer with HER2 mutations com … Recruiting
  2025-521284-12-00 5 2026-03-05
• A Phase 1 Study for ZW191 in Participants with Solid Tumors Recruiting
  2024-512299-37-00 1 2026-02-18 "Advanced solid tumors"
• A Study to Assess Adverse Events, Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Ad … Recruiting
  2025-521124-29-00 10 2026-02-13 "Non-Small Cell Lung Cancer"
• Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Part … Recruiting
  2025-522151-26-00 5 2026-02-06 "Advanced or Metastatic Non-Small-Cell Lung Cancer With Epide"
• A Multicenter, Open-label, Randomized Phase 3 Study Evaluating THIO Sequenced with Cemiplimab (LIBTAYO®) vs Investigator Choice of Single-ag … Recruiting
  2024-520164-33-00 5 2025-12-09 "Non-Small Cell Lung Cancer"
• A Study to Learn About the Study Medicine Called PF-08046054/SGNPDL1V Versus Docetaxel in Adult Participants with Previously-treated Program … Recruiting
  2025-521281-97-00 5 2025-12-02 "Non-Small Cell Lung Cancer (NSCLC)"
• A randomized multicenter Phase II trial evaluating oral pooled fecal microbiotherapy (MaaT033) concomitant to Cemiplimab (CB) versus best in … Recruiting
  2024-517018-14-00 4 2025-11-17 "Advanced non-small cell lung cancer"
• A Study in TKI-naive Patients With Advanced ALK-Positive NSCLC ( ALKAZAR ) Recruiting
  2024-517553-26-00 5 2025-11-12 "Advanced ALK-positive non-small cell lung cancer (NSCLC)"
• TransBronchial Needle injection of Tremelimumab in early-stage NSCLC patients (TALENT) Recruiting
  2024-511878-67-00 9 2025-11-03 "Non small cell lung cancer"

Showing 25–48 of 234 trials